NCT07404332 2026-02-115-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory TumorsUniversity of IowaPhase 1 Not yet recruiting35 enrolled
NCT06769698 2025-12-16A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaRegeneron PharmaceuticalsPhase 2 Not yet recruiting120 enrolled